Long-term nitrofurantoin: an analysis of complication awareness, monitoring, and pulmonary injury cases

Background: Long-term nitrofurantoin (NF) treatment can result in pulmonary and hepatic injury. Current guidelines do not outline the type or frequency of monitoring required for detection of these injuries. Aim: To assess 1) awareness of NF complications among prescribers; 2) monitoring practice; a...

Full description

Bibliographic Details
Published in:	BJGP Open
Main Authors:	Toby Peter Speirs, Nicole Tuffin, Finlay Mundy-Baird, Helena Sakota, Sarah Mulholland, Michelle Westlake, Max Lyon, Andrew R Medford, Charles Sharp, Michael Darby, Mahableshwar Albur, Francis Keeley, Helena Burden, Charlie Kenward, Elizabeth Jonas, Shaney Barratt, Huzaifa I Adamali
Format:	Article
Language:	English
Published:	Royal College of General Practitioners 2021-10-01
Subjects:	nitrofurantoin general practice urology drug-related side effects and adverse reactions prescription drug monitoring programs
Online Access:	https://bjgpopen.org/content/5/6/BJGPO.2021.0083

Similar Items

Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin
by: Jitendra Singh, et al.
Published: (2016-01-01)

A rare case of nitrofurantoin‐induced acute lung injury
by: Rehan Karmali, et al.
Published: (2020-10-01)

Consider Nitrofurantoin as a Cause of Lung Injury
by: Paulo Almeida, et al.
Published: (2019-10-01)

Nitrofurantoin-induced splinter hemorrhages: A forgotten culprit
by: Ana Sofia Acosta, MD, et al.
Published: (2024-05-01)

In Vitro and In Vivo Trypanocidal Efficacy of Synthesized Nitrofurantoin Analogs
by: Linous Munsimbwe, et al.
Published: (2021-06-01)

Nitrofurantoin susceptibility profile versus other antibiotics tested in uropathogens- a retrospective study from India
by: Anuja Gupta, et al.
Published: (2024-07-01)

Differentiating probable nitrofurantoin-induced drug fever from antipsychotic-induced hyperthermia in a patient receiving clozapine
by: Stephen B. Vickery, PharmD, BCPS, et al.
Published: (2022-06-01)

Nitrofurantoin-induced immune-mediated lung and liver disease
by: Milić Rade, et al.
Published: (2012-01-01)

Nitrofurantoin inhibits contractions of myometrium isolated from pregnant and nonpregnant rats
by: Ebru Celik Kavak, et al.
Published: (2018-06-01)

Nitrofurantoin-Induced Pulmonary Toxicity: Mechanisms, Diagnosis, and Management
by: Alan D. Kaye, et al.
Published: (2025-05-01)

Nitrofurantoin: properties and potential in treatment of urinary tract infection: a narrative review
by: Marzie Mahdizade Ari, et al.
Published: (2023-07-01)

Development of a Physiologically Based Pharmacokinetic Model for Nitrofurantoin in Rabbits, Rats, and Humans
by: Raju Prasad Sharma, et al.
Published: (2023-08-01)

The Effect of Nitrofurantoin on Tonic Seizures Induced by MES in Male Mice
by: Azin Jalalian, et al.
Published: (2024-06-01)

Progress in Electrode Materials for the Detection of Nitrofurazone and Nitrofurantoin
by: Mohammad Aslam, et al.
Published: (2025-07-01)

The effects of nitrofurantoin on rat urinary bladder contraction
by: Emine Kacar, et al.
Published: (2019-03-01)

Reduced Graphene Oxide/β-Cyclodextrin Nanocomposite for the Electrochemical Detection of Nitrofurantoin
by: Al Amin, et al.
Published: (2025-07-01)

Nitrofurantoin-induced radiation recall dermatitis
by: Ian Garrahy, et al.
Published: (2019-05-01)

Acute onset nitrofurantoin‐induced autoimmune hepatitis after urinary tract infection treatment
by: Ammad Javaid Chaudhary, et al.
Published: (2024-06-01)

Nitrofurantoin and Fosfomycin Susceptibility Among Outpatient Uropathogens in a Tertiary Care Center in Southern Thailand
by: Tharntip Sangsuwan, et al.
Published: (2018-05-01)

Therapeutic Efficacy of Orally Administered Nitrofurantoin against Animal African Trypanosomosis Caused by <i>Trypanosoma congolense</i> Infection
by: Keisuke Suganuma, et al.
Published: (2022-03-01)

Failure Rate of Oral Nitrofurantoin in Treating UTIs caused by ESBL-Producing Escherichia coli and Klebsiella pneumoniae : A Retrospective Cohort Study
by: Ossama Alrehaili, et al.
Published: (2025-08-01)

Combined Effect of Nitrofurantoin and Plant Surfactant on Bacteria Phospholipid Membrane
by: Monika Rojewska, et al.
Published: (2020-05-01)

Ultrafast green synthesis of silver nanoparticles as fluorescent nanosensors for determination of isoniazid and nitrofurantoin in biological fluids and pharmaceuticals
by: Galal Magdy, et al.
Published: (2025-05-01)

A pioneering electrochemical sensor for the simultaneous determination of nitrofurantoin and furazolidone residues in food and municipal wastewater samples
by: Wondimeneh Dubale Adane, et al.
Published: (2024-08-01)

Enhanced Drug Dissolution of Nitrofurantoin Using a Solid Dispersion Technique
by: D. S. Bhosale, et al.
Published: (2024-08-01)

Efficacy of Five Days Nitrofurantoin Therapy versus Fosfomycin Stat Dose in Clinical Resolution of Uncomplicated Urinary Tract Infections
by: Hasham Bin Tahir, et al.
Published: (2023-02-01)

Does Nitrofurantoin Improve the Portfolio of Vets against Resistant Bacteria in Companion Animals?
by: Cristina Vercelli, et al.
Published: (2023-05-01)

Repurposing nitrofurantoin as a stimulant of fibroblast extracellular matrix repair for the treatment of emphysema
by: Mathew N. Leslie, et al.
Published: (2024-09-01)

IN-VITRO EFFICACY OF NITROFURANTOIN, CIPROFLOXACIN AND COTRIMOXAZOLE AGAINST VARIOUS URINARY ISOLATES
by: Luqman Satti, et al.
Published: (2015-01-01)

Recurrent nitrofurantoin-induced giant cell interstitial pneumonia: Case report and literature review
by: Boeun Lee, et al.
Published: (2015-01-01)

High-level nitrofurantoin resistance in a clinical isolate of Klebsiella pneumoniae: a comparative genomics and metabolomics analysis
by: Maytham Hussein, et al.
Published: (2024-01-01)

Analysis of nitrofurantoin sensitivity in multi drug resistant gram negative bacilli causing UTI in a teaching hospital – A cost effective option
by: T Sabarinathan, et al.
Published: (2024-02-01)

Analysis of nitrofurantoin sensitivity in multi drug resistant gram negative bacilli causing UTI in a teaching hospital – A cost effective option
by: T Sabarinathan, et al.
Published: (2024-02-01)

Real-Life Comparison of Fosfomycin to Nitrofurantoin for the Treatment of Uncomplicated Lower Urinary Tract Infection in Women
by: Asher Shafrir, et al.
Published: (2023-03-01)

Risks of long-term use of nitrofurantoin for urinary tract prophylaxis in the older patient
by: Lauren L. Rego, et al.
Published: (2016-12-01)

Susceptibility Profile of Nitrofurantoin and Fosfomycin among Carbapenem-resistant Enterobacteriaceae Isolates in UTI from a Tertiary Care Hospital
by: Januki Kalai, et al.
Published: (2023-03-01)

Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in <i>Escherichia coli</i> Isolated in Clinical Urine Samples
by: Antonio Sorlozano-Puerto, et al.
Published: (2020-08-01)

Treatment of Non - Complicated Lower Urinary Tract Infection in Pregnancy: Single Dose Fosfomycin Tromethamine Versus Multiple Dose Nitrofurantoin
by: Murat Özel, et al.
Published: (2011-04-01)

Evaluation of antimicrobial effect of nitrofurantoin against other intracanal medicaments: An in vitro study
by: K. Sripriya, et al.
Published: (2025-04-01)

Nitrofurantoin and Fosfomycin for Extended Spectrum Beta-lactamases Producing Escherichia coli and Klebsiella pneumoniae
by: Neeraj Kumar Tulara
Published: (2018-01-01)